Biotech company StemCells Inc. (Nasdaq STEM) reported a third quarter net loss of $4.86 million, compared to a net loss of $94 thousand in the year ago quarter. Net loss for the quarter was $0.06 per share, compared to breakeven in prior year. Revenue from grants and licensing agreements was $18 thousand, compared to $91 thousand in the prior year quarter.